Headlands Technologies LLC Invests $154,000 in Astera Labs, Inc. (NASDAQ:ALAB)

Headlands Technologies LLC acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 1,165 shares of the company’s stock, valued at approximately $154,000.

Several other institutional investors also recently bought and sold shares of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Astera Labs by 5.7% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,284 shares of the company’s stock valued at $277,000 after acquiring an additional 284 shares in the last quarter. Verition Fund Management LLC purchased a new stake in Astera Labs in the 3rd quarter valued at approximately $1,524,000. Quarry LP acquired a new position in Astera Labs during the 3rd quarter worth approximately $109,000. Stifel Financial Corp grew its holdings in Astera Labs by 141.2% during the third quarter. Stifel Financial Corp now owns 98,461 shares of the company’s stock worth $5,158,000 after acquiring an additional 57,638 shares during the period. Finally, State Street Corp grew its stake in shares of Astera Labs by 173.1% during the 3rd quarter. State Street Corp now owns 698,467 shares of the company’s stock worth $36,593,000 after purchasing an additional 442,698 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on ALAB. Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 price target for the company in a research report on Tuesday, January 28th. Raymond James started coverage on Astera Labs in a research report on Friday, March 14th. They set an “outperform” rating and a $82.00 target price on the stock. Morgan Stanley dropped their price target on Astera Labs from $142.00 to $114.00 and set an “equal weight” rating for the company in a research report on Tuesday, January 28th. Stifel Nicolaus boosted their price objective on shares of Astera Labs from $100.00 to $150.00 and gave the stock a “buy” rating in a research report on Monday, January 6th. Finally, Needham & Company LLC restated a “buy” rating and set a $140.00 target price on shares of Astera Labs in a report on Tuesday, February 11th. One equities research analyst has rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $112.77.

Insider Activity at Astera Labs

In related news, Director Manuel Alba sold 63,000 shares of Astera Labs stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $63.37, for a total transaction of $3,992,310.00. Following the transaction, the director now owns 444,863 shares in the company, valued at approximately $28,190,968.31. The trade was a 12.40 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Michael Truett Tate sold 125,800 shares of the firm’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $82.53, for a total value of $10,382,274.00. Following the completion of the transaction, the chief financial officer now directly owns 244,242 shares in the company, valued at $20,157,292.26. This trade represents a 34.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 633,990 shares of company stock worth $54,235,012.

Astera Labs Trading Down 4.9 %

Shares of NASDAQ:ALAB opened at $52.94 on Friday. Astera Labs, Inc. has a 12-month low of $36.22 and a 12-month high of $147.39. The stock’s 50-day moving average price is $78.49 and its two-hundred day moving average price is $90.74. The firm has a market cap of $8.58 billion and a price-to-earnings ratio of -30.60.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Monday, February 10th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative net margin of 21.05% and a negative return on equity of 10.40%. As a group, research analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.